| CAS ID: | 1318075-13-6 |
| Molecular Formula: | |
| Molecular Weight: | g/mol |
| Monoisotopic Mass: | g/mol |
| Class: | Monoclonal antibody |
| Natural Product: | No |
| Other Names: | |
| Analysis: | N/A |
Reference Record 1
| PubMed ID | 23821193 | Target ID | |
| Uniprot ID | Name | ||
| Model | rabbit | Fibrosis Disease | Scar |
| Process I | attenue inflammation | ||
| Process II | |||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT01452308 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | October 14, 2011 | Last Verified | February 3, 2014 |
| Sponsor | Gilead Sciences | ||
Trial Record 2
| ClinicalTrial ID | NCT01362231 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | May 30, 2011 | Last Verified | July 9, 2015 |
| Sponsor | Gilead Sciences | ||
Trial Record 3
| ClinicalTrial ID | NCT01759511 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | January 3, 2013 | Last Verified | April 4, 2017 |
| Sponsor | Gilead Sciences | ||
Trial Record 4
| ClinicalTrial ID | NCT01769196 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | January 16, 2013 | Last Verified | May 30, 2017 |
| Sponsor | Gilead Sciences | ||
Trial Record 5
| ClinicalTrial ID | NCT01707472 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | October 16, 2012 | Last Verified | December 16, 2015 |
| Sponsor | Gilead Sciences | ||
Trial Record 6
| ClinicalTrial ID | NCT02466516 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | June 9, 2015 | Last Verified | February 27, 2017 |
| Sponsor | Gilead Sciences | ||
Trial Record 7
| ClinicalTrial ID | NCT01672866 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | August 27, 2012 | Last Verified | May 4, 2018 |
| Sponsor | Gilead Sciences | ||
Trial Record 8
| ClinicalTrial ID | NCT01672853 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | August 27, 2012 | Last Verified | February 24, 2017 |
| Sponsor | Gilead Sciences | ||
Trial Record 9
| ClinicalTrial ID | NCT01672879 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | August 27, 2012 | Last Verified | May 4, 2018 |
| Sponsor | Gilead Sciences | ||
| PubChem: | 381126979 |
| ChEMBL: |